Skyward Specialty Insurance Group has secured regulatory and shareholder approvals to acquire Lloyd's specialist Apollo Group Holdings for $555 million. The transaction, expected to close in Q1 2026, supports strong financial guidance for 2026 including gross written premiums up to $2.8B and a combined ratio near 91%.

UnitedHealth Group's unexpected CEO replacement and 2025 guidance withdrawal reflect rising Medicare Advantage costs and market uncertainty, impacting stock performance and investor confidence.

UnitedHealth downgraded to Neutral by BofA after suspending 2025 guidance due to Medicare Advantage challenges. Analyst price targets and ratings vary amid uncertainty.

Elevance Health lowers full-year profit forecast despite Q1 revenue growth driven by higher premiums and membership gains in Medicare Advantage and ACA.